Alvarez Eduardo

Avg. Two Year Performance

(48%) Avg. Purchase Return
(22%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(3%)(32%)(30%)(42%)(48%)
Purchase Success Rate0 of 21 of 20 of 20 of 20 of 2
Average Sale Return0%0%0%0%0%
Sale Success Rate0 of 10 of 10 of 10 of 10 of 1

Amyris, Inc.

Drugs » Biotechnology

Chief Operating Officer:

Holdings: 612.55K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--